Eigen Company Profile
Download as PPT, PDF1 like12,945 views
Eigen is a privately-held company focused on improving healthcare through innovations in image-guided diagnosis and treatment of prostate cancer, with $50 million invested and 25+ patents. The market for prostate cancer therapies is projected at $5 billion by 2015, with Eigen's products including a 3D image-guided biopsy system that aids in accurate disease management. The company aims to capitalize on significant market opportunities as 1 in 6 men will face prostate cancer in their lifetime.
Eigen Company Profile
- 2. Mission Statement Eigen strives to improve healthcare and quality of life through innovations in image-guided diagnosis and treatment of diseases.
- 3. About Eigen • Privately-held company with ~$50M invested • Two 510(k) approvals – Plus one application pending • IP includes 25+ patents – issued, licensed and pending • 30+ scientific publications
- 4. About Eigen • Core Competencies – New product development R&D, engineering and commercialization – Medical imaging – Prostate cancer • 23 Employees – Medical imaging scientists, R&D, biomedical, manufacturing and electromechanical engineers
- 5. Market Opportunities • 1 in 6 men will get prostate cancer in his lifetime • Estimated new cases and deaths from prostate cancer in the U.S. in 2012: – New cases: 241,740 – Deaths: 28,170 (Source: National Cancer Institute) • Over 1 million biopsies performed the in U.S. annually
- 6. Market Opportunities • Prostate cancer minimally-invasive device surgical market in North America and Europe estimated to be: – $14.2B in 2011 – Expected to reach $24.9B by 2016 CAGR of 11.0% between 2011—2016 – Monitoring and visualization segment is leading market contributor ~38% share in 2011 (source: Transparency Market Research)
- 7. Market Opportunities • Prostate cancer therapies market expected to be worth $5 billion in U.S. by 2015
- 8. Product Portfolio • Urology applications – 3D image-guided biopsy system (Artemis) Provides accurate guidance using 3D ultrasound imaging Records precise prostate biopsy locations Aids in disease management Aids in early detection
- 9. Product Portfolio MRI TRUS Prostate • Radiology applications Lesion – MRI/TRUS fusion guidance • Uses MRI for diagnosis of prostate cancer • Provides accurate guidance to suspected lesions – Interventional cardiology
- 10. Products in Pipeline • Urology Applications • 3D image-guided therapy system • Upgrades on Artemis (2.1 and 3.0) • Radiology Applications • ProFuse • eiView Workstation • DSA 2000
- 11. Artemis Hardware Tracker Establishes and maintains a frame of Arm reference between Positions device patient and 3D TRUS relative to a patient image Cradle Touchscreen Interfaces Artemis Monitor hardware with specific OEM probe
- 12. Artemis Workflow Scan Capture 3D scan Compute prostate boundaries Plan Load a plan or select sites in 3D volume Biopsy Maneuver arm to perform targeted biopsies Record sample Report core locations Review images Update or add pathological findings
- 13. Artemis Smart BiopsyTM How an Artemis-assisted Smart Conventional Smart Biopsy compares with a Ultrasound Prostate traditional Biopsy Biopsy BiopsyTM 3D color real-time display - Mapping and planning - Accurate needle guidance - Biopsy recording & review - Modern imaging technology - Advanced diagnostic info - Provides baseline of prostate biopsy - data Targeted repeat biopsies -
- 14. Market Presence
- 17. Eigen in News Feature Article - Sep 2011
- 18. www.eigen.com www.smartprostatebiopsy.com 13366 Grass Valley Ave. Grass Valley, CA 95945 USA Phone: (888) 924-2020 (530) 274-1240 Fax: (530) 274-3656